Literature DB >> 30205243

Minimum structural requirements for BMP-2-binding of heparin oligosaccharides.

Raymond A A Smith1, Sadasivam Murali1, Bina Rai1, Xiaohua Lu1, Zophia Xue Hui Lim1, Jaslyn J L Lee1, Victor Nurcombe2, Simon M Cool3.   

Abstract

Bone morphogenetic proteins (BMPs) are essential during tissue repair and remodeling after injury. Glycosaminoglycan (GAG) sugars are known to enhance BMP activity in vitro and in vivo; here the interactions of BMP-2 with various glycosaminoglycan classes were compared and shown to be selective for heparin over other comparable saccharides. The minimal chain lengths and specific sulfate moieties required for heparin-derived oligosaccharide binding to BMP-2, and the ability of such oligosaccharides to promote BMP-2-induced osteogenic differentiation in vitro were then determined. BMP-2 could bind to heparin hexasaccharides (dp6) and octasaccharides (dp8), but decasaccharides (dp10) were the minimum chain length required for both efficient binding of BMP-2 and consequent heparin-dependent cell responses. N-sulfation is the most important, and 6-O-sulfation moderately important for BMP-2 binding and activity, whereas 2-O-sulfation was much less critical. Bone formation assays in vivo further confirmed that dp10, N-sulfated heparin oligosaccharides were the minimal requirement for effective enhancement of BMP-2-induced bone formation. Such information is necessary for the rational design of the next generations of heparan-based devices for bone tissue repair.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BMP-2; Bone repair; Glycosaminoglycan; Heparin

Mesh:

Substances:

Year:  2018        PMID: 30205243     DOI: 10.1016/j.biomaterials.2018.08.056

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Engineer P. multocida Heparosan Synthase 2 (PmHS2) for Size-Controlled Synthesis of Longer Heparosan Oligosaccharides.

Authors:  Lan Na; Hai Yu; John B McArthur; Tamashree Ghosh; Thomas Asbell; Xi Chen
Journal:  ACS Catal       Date:  2020-05-11       Impact factor: 13.084

2.  FGFR2 accommodates osteogenic cell fate determination in human mesenchymal stem cells.

Authors:  Ying Zhang; Ling Ling; Arya Ajay D/O Ajayakumar; Yating Michelle Eio; Andre J van Wijnen; Victor Nurcombe; Simon M Cool
Journal:  Gene       Date:  2022-01-29       Impact factor: 3.913

Review 3.  The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials.

Authors:  Jing Wang; Lan Xiao; Weiqun Wang; Dingmei Zhang; Yaping Ma; Yi Zhang; Xin Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-12

4.  Composite Cryogel with Polyelectrolyte Complexes for Growth Factor Delivery.

Authors:  Bolat Sultankulov; Dmitriy Berillo; Sholpan Kauanova; Sergey Mikhalovsky; Lyuba Mikhalovska; Arman Saparov
Journal:  Pharmaceutics       Date:  2019-12-04       Impact factor: 6.321

5.  Co-Cr-Mo-Cu alloys for clinical implants with osteogenic effect by increasing bone induction, formation and development in a rabbit model.

Authors:  Jingzhu Duan; Yang Yang; Erlin Zhang; Huan Wang
Journal:  Burns Trauma       Date:  2020-12-21

6.  Selective endocytosis of recombinant human BMPs through cell surface heparan sulfate proteoglycans in CHO cells: BMP-2 and BMP-7.

Authors:  Mi Gyeom Kim; Che Lin Kim; Young Sik Kim; Ju Woong Jang; Gyun Min Lee
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

Review 7.  Proteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration.

Authors:  Jiawen Chen; Tianyu Sun; Yan You; Buling Wu; Xiaofang Wang; Jingyi Wu
Journal:  Front Cell Dev Biol       Date:  2021-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.